Boston Private Bank & Trust’s AbbVie ABBV Stock Holding History

Boston Private Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$17.3M	Sell	294,923 -715	-0.2%	-$43.2K	0.8%	40
2014 Q4	$19.3M	Buy	295,638 +58	+0%	+$3.66K	0.9%	31
2014 Q3	$17.1M	Sell	295,580 -1,066	-0.4%	-$59.2K	0.83%	35
2014 Q2	$16.7M	Buy	296,646 +15,132	+5%	+$794K	0.81%	36
2014 Q1	$14.5M	Sell	281,514 -2,118	-0.7%	-$107K	0.73%	42
2013 Q4	$15M	Sell	283,632 -923	-0.3%	-$45.4K	0.75%	42
2013 Q3	$12.7M	Sell	284,555 -4,307	-1%	-$191K	0.71%	45
2013 Q2	$11.9M	Buy	+288,862	New	+$12.6M	0.7%	44

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boston Private Bank & Trust's ABBV Position: Q1 2015 in Review

Boston Private Bank & Trust reduced its AbbVie (ABBV) stake by 0.24% in Q1 2015, selling an estimated $43.2K and leaving 294,923 shares worth $17.3M. The position accounts for 0.8% of the portfolio, ranked #40.

Boston Private Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 8 quarters since. The position peaked at $19.3M in Q4 2014. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

Boston Private Bank & Trust held 294,923 shares of AbbVie worth $17.3M as of Q1 2015.
Boston Private Bank & Trust sold 715 AbbVie shares in Q1 2015, an estimated $43.2K.
AbbVie made up 0.8% of Boston Private Bank & Trust's portfolio in Q1 2015, its #40 holding.
Boston Private Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 8 quarters since.
Boston Private Bank & Trust's AbbVie position peaked at $19.3M in Q4 2014.
1,601 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.